Centene — Jul 28, 2026 release
Fiscal 2026 second-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0001071739-26-000154
Showing in the filing
Adjusted SG&A expense ratio (2)
“6.9%” – “7.5%”
Period
FY2026
Measure
Company-defined measure
Source
Guidance table
All guidance in this release · 15
Total revenues for FY2026
“$193.5 billion to $197.5 billion”
Premium and service revenues for FY2026
“$173.0 billion to $177.0 billion”
Investment and other income expectation for FY2026
“$1.50 billion”
GAAP diluted EPS floor for FY2026
“greater than $3.11”
Adjusted diluted EPS floor for FY2026
“greater than $4.80”
Total revenues (in billions) for FY2026
“$193.5” – “$197.5”
Premium and service revenues (in billions) for FY2026
“$173.0” – “$177.0”
HBR for FY2026
“90.5 % 91.3 %”
SG&A expense ratio for FY2026
“7.2 % 7.8 %”
Adjusted SG&A expense ratio for FY2026
“6.9 % 7.5 %”
Effective tax rate for FY2026
“26.5 % 27.5 %”
Adjusted effective tax rate for FY2026
“25.5 % 26.5 %”
Adjusted effective tax rate (3) for FY2026
“25.5%” – “26.5%”
Diluted shares outstanding (in millions) for FY2026
“497.0” – “500.0”
Adjusted SG&A expense ratio (2) for FY2026
“6.9%” – “7.5%”
Exhibit 99.1 · the passage around this item
… earlier in the release
NUMBER OF EMPLOYEES 59,800 61,000 61,100 60,900 60,300 DAYS IN CLAIMS PAYABLE 47 48 46 48 47 CASH, INVESTMENTS AND RESTRICTED DEPOSITS (in millions) Regulated $ 43,015 $ 40,239 $ 37,289 $ 37,574 $ 36,403 Unregulated 1,831 1,533 1,478 1,259 1,086 Total $ 44,846 $ 41,772 $ 38,767 $ 38,833 $ 37,489 DEBT TO CAPITALIZATION 41.6 % 43.2 % 46.5 % 45.5 % 39.0 % OPERATING RATIOS Three Months Ended June 30, Six Months Ended June 30, 2026 2025 2026 2025 HBR 89.6 % 93.0 % 88.4 % 90.2 % SG&A expense ratio 7.0 % 7.1 % 7.3 % 7.5 % Adjusted SG&A expense ratio 6.9 % 7.1 % 7.2 % 7.5 % HBR BY PRODUCT Three Months Ended June 30, Six Months Ended June 30, 2026 2025 2026 2025 Medicaid 93.9 % 94.9 % 93.5 % 94.2 % Commercial 79.2 % 90.6 % 77.2 % 82.8 % Medicare (5) 89.5 % 90.9 % 87.3 % 88.6 % (5) Medicare includes Medicare Advantage, Medicare PDP and Medicare Supplement. 12 MEDICAL CLAIMS LIABILITY The changes in medical claims liability are summarized as follows (in millions): Balance, June 30, 2025 $ 20,117 Less: Reinsurance recoverables 60 Balance, June 30, 2025, net 20,057 Incurred related to: Current period 161,849 Prior periods (1,737) Total incurred 160,112 Paid related to: Current period 142,602 Prior periods 16,854 Total paid 159,456 Plus: Premium deficiency reserve (389) Plus: Divestitures (109) Balance, June 30, 2026, net 20,215 Plus: Reinsurance recoverables 47 Balance, June 30, 2026 $ 20,262 Centene's claims reserving process utilizes a consistent actuarial methodology to estimate Centene's ultimate liability. Any reduction in the "Incurred related to: Prior periods" amount may be offset as Centene actuarially determines the "Incurred related to: Current period." Additionally, approximately $22 million was re
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.